Program
Tumor Infiltrating Lymphocytes and
Virus Specific T-Cells
Competence Center for Vaccines and Messenger RNA Therapies
National Institute of Science
and Technology – Multiomics Applied to Precision Health
National Institute of Science and
Technology in Precision Oncology
Therapy
Gene Therapy – Translation and
Clinical Trials
Mesenchymal Stem Cells
National Institute of Gene Therapy
EMBRAPII Einstein Competence Center for Advanced Therapies
IGI Session
Past, Present and Future of AAVs
National Institute of Science and Technology in Translational Oncology and Gene Therapies
National Institute of Science and Technology in Complex Human Disease Modeling with 3D Platforms
Poster format:
Regulations for submitting abstracts to Cel-Gen 2026
All abstracts must be written in English, and abstracts selected for oral presentation must also be presented in English.
Submission opening and closing date/time:
Opening: June 1st
Closing: June 30, 12:00 a.m. (midnight) Postponed to August 02, 12:00 a.m. (midnight)
Maximum number of abstracts per author: 3 abstracts
Maximum number of authors per abstract: 15 authors
Title length limit: 250 characters (including spaces)
Abstract length limit: Abstracts are limited to 3,000 characters, including punctuation and spaces (excluding title, authors, and affiliations)
Authors may submit abstracts before completing registration/payment. Registration fees will only be required after abstract acceptance.
Evaluation score/rating scale: up to 6 points
Work presentation formats: Poster and Oral Presentation
Categories:
Questions: contact@abtcelgen.org.br; temalivre3@mezclaeventos.com.br